Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 17.995 USD 0.98% Market Closed
Market Cap: 129.7m USD

Wall Street
Price Targets

ATRA Price Targets Summary
Atara Biotherapeutics Inc

Wall Street analysts forecast ATRA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRA is 17.34 USD with a low forecast of 16.16 USD and a high forecast of 18.9 USD.

Lowest
Price Target
16.16 USD
10% Downside
Average
Price Target
17.34 USD
4% Downside
Highest
Price Target
18.9 USD
5% Upside
Atara Biotherapeutics Inc Competitors:
Price Targets
MDXH
MDxHealth SA
116% Upside
196170
Alteogen Inc
25% Upside
ELDN
Eledon Pharmaceuticals Inc
398% Upside
KMDA
Kamada Ltd
114% Upside
LXRX
Lexicon Pharmaceuticals Inc
126% Upside
ASND
Ascendis Pharma A/S
21% Upside
DAWN
Day One Biopharmaceuticals Inc
171% Upside
2171
CARsgen Therapeutics Holdings Ltd
48% Upside

Revenue
Forecast

Revenue Estimate
Atara Biotherapeutics Inc

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 4 years is -10%.

N/A
Past Growth
-10%
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATRA's stock price target?
Price Target
17.34 USD

According to Wall Street analysts, the average 1-year price target for ATRA is 17.34 USD with a low forecast of 16.16 USD and a high forecast of 18.9 USD.

What is Atara Biotherapeutics Inc's Revenue forecast?
Projected CAGR
-10%

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 4 years is -10%.

Back to Top